Fortrea Holdings INC 8-K filings

NASDAQ

16 May 2024

FTRE

8-K: Fortrea Appoints Machelle Sanders to Board of Directors, Holds Annual Meeting

Fortrea Holdings Inc. has appointed Machelle Sanders to its Board of Directors and held its 2024 Annual Meeting of Stockholders, where key proposals were voted on.

NASDAQ

13 May 2024

FTRE

Fortrea Holdings INC

8-K: Fortrea Reports Mixed Q1 2024 Results Amidst Strategic Divestiture

Fortrea's first quarter of 2024 saw a revenue decrease and a net loss, but the company is progressing with its planned divestiture and focusing on future growth.

NASDAQ

9 May 2024

FTRE

Fortrea Holdings INC

8-K: Fortrea Secures $300 Million Receivables Facility and Amends Credit Agreement

Fortrea Holdings Inc. has established a $300 million receivables securitization program and amended its credit agreement to increase financial flexibility.

NASDAQ

1 Apr 2024

FTRE

Fortrea Holdings INC

8-K: Fortrea Holdings Inc. Announces Board Member Resignation and Accelerated Vesting of Stock Options

Fortrea Holdings Inc. reports the resignation of board member Betty Larson due to a significant change in her principal occupation, effective March 30, 2024, and the acceleration of her stock option vesting.

NASDAQ

11 Mar 2024

FTRE

Fortrea Holdings INC

8-K: Fortrea Announces 2023 Financial Results and Divestiture of Endpoint Clinical and Patient Access Businesses

Fortrea reported its 2023 financial results, including a net loss for the year, and announced the divestiture of its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners.